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Objective: Quality of life studies in Indonesia are still uncommon. This research was aimed
to validate the European Organization for Research and Treatment of Cancer Quality of Life
Questionnaire-C30 in Indonesian version. The standard procedure of forward–backward
translation was adhered to in the translation procedures. The validity procedure included
reliability, convergent and discriminant validity, known-groups validity, factor analysis
and external convergent validity.
Methods: Data were collected from cancer patients in the Oncology Department of Sardjito
Hospital, Yogyakarta, Indonesia, who were treated with cisplatin at the dosage 50 mg/m2 as
monotherapy or in combinations. The Short Form-36 was used to assess the external
convergent validity of our translated questionnaire.
Results: One hundred and twenty-eight patients were recruited from March 2009 to
November 2009. The internal consistency with values of .0.70 was observed in the
Indonesian version of the European Organization for Research and Treatment of Cancer
Quality of Life Questionnaire-C30 scales. All items in the questionnaire met the criteria of con-
vergent and discriminant validity, except for items 5. Both of the European Organization for
Research and Treatment of Cancer Quality of Life Questionnaire-C30 and the Short Form-36
showed that different diagnoses were associated with a similar impact on quality of life.
Factor analysis showed that only the role function and social function loaded onto the second
factor together. Correlations between the Indonesian versions of both questionnaires were
moderate: between 0.18 and 0.48 for the physical, emotional, social, fatigue and pain
domains.
Conclusions: The Indonesian version of the European Organization for Research and
Treatment of Cancer Quality of Life Questionnaire-C30 can be used as a questionnaire to
assess quality of life in Indonesian cancer patients with high-emetogenic treatments.
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BACKGROUND
Cancer and the side effects of cancer treatment are often
associated with reduced quality of life (QoL) (1). Although
advances in cancer treatment could improve the outcome of
therapy in cancer patients, such as survival rate and disease-
free conditions, patients continue to experience a major
impact of cancer and its treatment on numerous physical and
psychosocial conditions. This may consequently affect the
patients’ normal patterns in their social activities, psychoso-
cial and spiritual well-being (2–4). Combining treatment
strategy with QoL assessment is considered necessary. In
modern cancer care, the views of patients are key in cancer
treatment and patient reported outcomes assessment is the
future trend in cancer therapy. Moreover, QoL assessment is
required to consider the impact of cancer treatment on func-
tional and psychosocial health of patients (2). ‘Research on
QoL in cancer patients has developed in many countries
to know the patients’ outcome, with many articles of QoL
published annually’ (3).
Several instruments have been developed to assess QoL in
cancer patients in past decades (4). Combinations of generic
and disease-specific instruments have been applied to define
QoL in patients with multipathology. The European
Organization for Research and Treatment of Cancer Quality
of Life Core Questionnaire (EORTC QLQ-C30) has been
used internationally in ‘more than 3000 studies’ as generic a
questionnaire among cancer patients. As stated in the paper
by Kleijn et al. ‘This questionnaire has been translated into
and validated into more than 50 languages’ (5).
The EORTC QLQ-C30 and the Medical Outcomes
Study Short Form 36 (SF-36) have five domains in common:
physical function, mental health/emotional function, social
function, vitality/fatigue and pain. The two questionnaires
are often used to discover the convergent validity of the
similar constructs between them. A previous study in non-
malignant pain used these questionnaires and demonstrated
that both of the questionnaires had acceptable psychometric
characteristics (4).
Information about cancer patients’ QoL in the Indonesian
population is inadequate. The publications in this field are
focused on children. A study about health-related QoL in
childhood with acute lymphoblastic leukemia suggested that
the patients and their family should be supported by psycho-
social care during the cancer treatments. Psychosocial care
during cancer interventions could improve patients’ QoL (6).
Consequently, the area of QoL research needs to be devel-
oped urgently in Indonesia in order that better supportive
care during cancer interventions may be proposed.
The limited research on QoL in Indonesia is associated
with the unavailability of validated questionnaires in
Indonesian versions. Therefore, the objective of this study
was to translate and linguistically validate the Indonesian
version of the EORTC QLQ-C30 in cancer patients. In this
study, the SF-36 was used a gold standard to test the external
convergent validity of QLQ-C30. The SF-36 questionnaire
has been translated into Indonesian version (7). The reason
for using SF-36 as gold standard was that the SF-36 has been
used and validated in the Indonesian version (8–12). The
Indonesian version of the EORTC QLQ-C30 encompassed
translations from the original English versions with forward-
backward translation, pilot testing, and review. In order to
obtain the Indonesian version of SF-36, the reader can contact
the author. The validity procedure includes reliability, multi-
factorial analysis, known-groups validity, factor analysis,
test-retest validity and external convergent validity.
PATIENTS AND METHODS
STEP 1: TRANSLATION PROCEDURES
The procedures for translation into the Indonesian language
were adapted from Koller et al. (13). The translation coordi-
nator contacted two experts in the English Department of two
universities independently to do the forward translation of
EORTC QLQ-C30. The research coordinator compared the
two forward translations and checked them for any discrepan-
cies. The discrepancies between the two translations were dis-
cussed with the translators until we agreed on the single
provisional forward translation. Modifications were made in
this draft to diminish discrepancies and it was adjusted with a
view to the habits of Indonesian people. The single forward
translation was then back translated by two native speakers of
English independently. The English back translations and the
original English version were compared with assure that there
was no different meaning of the questions in the question-
naires. The discrepancies were discussed and resolved until
agreement within the translation group was reached.
STEP II: PILOT TEST
The translated version of the EORTC QLQ-C30 was pilot
tested in 20 patients, who were recruited from a university
hospital in Yogyakarta, Indonesia. Inclusion criteria for the
pilot test were: cancer patients and healthy people; aged 18
years or older; ability to read and write standard Indonesian;
and willing to participate in the study. The Indonesian
version of EORTC QLQ-C30 was distributed to the patients
before their chemotherapy treatment, and to the healthy
people. Any difficulties that the patients had experienced
with the questionnaire were recorded by the researcher
during the time the patients completed the questionnaire.
The patients’ obstacles in understanding and completing the
questionnaires were reviewed and used to modify the ques-
tionnaires by the translation group.
STEP III: MAIN STUDY
SUBJECTS
The study population was made up of cancer patients in the
Oncology Department of Dr Sardjito Hospital, Yogyakarta,
Page 2 of 11 Validation of EORTC QLQ-C30 in Indonesia
 at Bibliotheek Instituut M
oleculaire Plantkunde on January 25, 2011
jjco.oxfordjournals.org
D
ow
nloaded from
 
Indonesia, who were treated with a cisplatin dosage 50 mg/
m2 as monotherapy or in combined chemotherapy regimens.
Patients aged 18 years old with a Karnofsky Index 50%
were included. Exclusion criteria were: patients with the pres-
ence of nausea or vomiting 24 h before chemotherapy; use of
other anti-emetics, benzodiazepines or neuroleptics or the
application of radiotherapy within 24 h before start of che-
motherapy and use of opioids within the previous 2 weeks.
We studied patients with cisplatin as subjects because
cisplatin is one of the cytotoxic agents which has a severe eme-
togenic effect and has a significant effect on patients’ QoL.
Dr Sardjito Hospital, Yogyakarta, is a tertiary care public hos-
pital with approximately 750 beds, and 250 beds among them
were third-class services. Most of the third-class patients are
supported by government health insurance in public and
private hospitals. Nevertheless, there are some third-class
patients who are not supported by government health insur-
ance. Thus, these patients could not pay to get good services
from a private hospital. This is due to the fact that the health
services in this hospital are dedicated to poor people.
DATA COLLECTION
Patient’s sociodemographic data such as age, sex, education,
diagnoses of cancer and performance status of patients based
on Karnofsky Performance Status (KPS) were collected from
their medical records. The procedure of the patients’ data col-
lection in the main study was done before administration of
cytotoxic drugs. After informed consent procedures were
completed, patients filled out questionnaires a few hours
before chemotherapy and on day 5 after chemotherapy admin-
istration at the hospital. The time of administration of the
questionnaire was based on a previous study (9). The study
was approved by the local ethics committee of the Faculty of
Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.
STATISTICAL ANALYSIS
Descriptive data are presented with means and standard devi-
ations (SDs). Discrimination of the instruments was tested
by floor and ceiling effects. Large floor and ceiling effects
are assumed to show poor discrimination of the instruments.
The internal consistency of each subscale was assessed
by using Cronbach’s a coefficient. It was considered to be
acceptable as good internal consistency occurs when
Cronbach’s a is 0.70 or greater. Multi-trait scaling analysis
was used to test the convergent and discriminant validity
of the EORTC QLQ-C30. Convergent validity was revealed
if the item–domain correlation was 0.40, while the
requirements for discriminant validity were satisfied if the
value of correlation coefficients between the item and its
own domain was higher than other domains. Known-groups
validity was evaluated based on different diagnoses using
T-test or ANOVA test. Factor analysis was used to extract
factors from 15 indicators of QoL in EORTC QLQ-C30.
Kaiser–Meyer–Olkin (KMO) and Bartlett’s test were tested
to know if the data were suitable for factor analysis. The
loading criterion was set at less than 0.40 of absolute value.
Convergence between instruments (external convergent val-
idity) evaluates correlations between similar domains of the
SF-36 and EORTC QLQ-C30. If one domain has a similar
underlying construct, it will show a high correlation with the
other domain. Pearson’s correlation was used to compute con-
struct validity. Correlations above 0.40 are considered satis-
factory for convergent validity. However, if this correlation is
too high (.0.70), it can be caused by different concept
measurements, or there may be some useful information
obtained by including the two domains compared with includ-
ing only one of the domains. Correlation coefficients of .0.5,
0.35–0.50 and ,0.35 were considered to represent strong,
moderate and low correlations, respectively. The discriminant
validity means that scales measuring different constructs
should have a low correlation, i.e. ,0.40 (2–4,14,15).
RESULTS
STEP I: TRANSLATION AND BACK-TRANSLATION
In the Indonesian version of SF-36, some questions were
adjusted to Indonesians’ habits and occupations. For
example: moderate activities such as moving a table, using a
vacuum cleaner, bowling or playing golf in item 3b, was
translated into ‘moving a table, cycling and working in the
garden’, as ‘using a vacuum cleaner, bowling and playing
golf’ are not done by most Indonesian people. Another
example, in the original version of SF-36, ‘walking more
than one mile’ in item 3g, was translated into ‘walking more
than 1.6 km, as Indonesian people use ‘kilometers’. In the
first draft of EORTC QLQ-C30, the medical words such as
insomnia, constipation and depression were translated into
non-medical word such as, difficult to sleep, difficult to
defecate and feeling stress.
There were some differences in the back-translations of
the questionnaire but the translators had the opinion that the
differences would not change the meaning of word, because
the Indonesian language has less vocabulary than the
English language. The differences in expression of the
response choices of the Likert-type scales were also present
between the back-translation versions and the original
version. But the translators had the opinion that the differ-
ences were only about the formal style of the language and
would not change the meaning of the expression. Therefore,
the expression of the response choices used the less formal
style, which is appropriate with the lower and middle levels
of education in these cancer patients.
STEP II: PILOT TEST
Twenty people (10 healthy people and 10 cancer patients)
were enrolled in the pilot test. The age range for the healthy
people varied from 19 to 49 years with a mean of 26.10
years (SD ¼ 8.88); the age range of cancer patients varied
from 26 to 63 years with a mean of 49.60 years (SD ¼ 9.83).
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The average completion time of translated version of the
EORTC QLQ-C30 were 4.54 minutes (SD ¼ 1.00) for
healthy people and 5.88 minutes (SD ¼ 1.97) for cancer
patients. Most patients were able to fill out the questionnaires
by themselves, except for items 29 and 30 in EORTC
QLQ-C30, where the patients needed an explanation about
the meaning of the QoL in the less formal language style and
about the differences between items 29 and 30. Item 29 in
EORTC QLQ-C30 asks the patients to rate their overall health
during this past week, whereas item 30 asks the patients to
rate their QoL. Generally, the subjects asked about the
meaning of QoL or asked to the researcher to give a short
description about QoL.
STEP III: MAIN STUDY
PATIENTS’ DEMOGRAPHIC DATA
One hundred and twenty-eight patients were recruited in this
study from March 2009 to November 2009. Patients had
different diagnoses of cancer. The most prevalent diagnostic
category was cervical cancer. The KPS scores less than 90%
were found in 57% of cancer patients, which means that
more patients needed some efforts to carry on normal
activity with some signs or symptoms of cancer than patients
with normal activity and minor signs or symptoms of cancer.
When we dichotomized the sample on the basis of KPS
scores less than 80% and 80–100% (n ¼ 118), we found that
the number of patients in the less than 80% group was 10
and the number of patients in the 80–100% group was 118.
Furthermore, sensitivity analyses regarding this point by, for
instance, dichotomizing the sample in less than or more than
70% on the KPS would run into difficulties as that would
imply comparing n ¼ 4 (for KPS less than 70%) with n ¼
124 (for KPS more than 70%). The demographic data of the
patients are shown in Table 1. In regard to educational
status, most of the patients only attended elementary school
level. This illustrates the low educational level experienced
by most of the patients in Dr Sardjito Hospital where the ser-
vices of this public hospital are dedicated to poor people.
DISCRIMINATION AND INTERNAL CONSISTENCY
Table 2 lists floor and ceiling effects of EORTC QLQ-C30
and SF-36. The large floor and ceiling effects were found in
single items, emotional function and cognitive function of
EORTC QLQ-C30 (0.8–92.2%). Whereas, the large floor
and ceiling effects in SF-36 were seen on physical and
emotional roles (11.1–76.2%).
The physical and role functions in SF-36 and the pain,
fatigue and single items in EORTC QLQ-C30 were question-
able following psychometric analysis (mean and SD), i.e.
mean: 16.5 and SD: 33.3 in the physical role domain of the
SF-36.
Cronbach’s a coefficients are presented in Table 2 for all
domains of the two questionnaires. This study found that for
the SF-36 values above 0.70 were observed in following
domains: physical function, social function, pain, physical
role and emotional role. In EORTC QLQ-C30, those five
domains were also valued above 0.70. This finding means
that for those five domains, EORTC QLQ-C30 has the same
reliability as SF-36. Furthermore, in EORTC QLQ-C30 the
values above 0.70 were not only observed in those five
domains, but also in all domains. We excluded the outlier
factor in the cognitive function to get a better value of
Cronbach’s a.
MULTI-TRAIT ANALYSIS
Table 3 shows that the convergent validity was revealed due
to all of the value of coefficient correlations between the
item and its own domain were 0.40, except for items 5,
10, 15 and 25. Table 3 also shows that all items meet the
discriminant validity criterion except for item 5 with the
value of 0.38.
KNOWN-GROUPS VALIDITY
The known-groups validity of the questionnaire among three
groups of diagnoses is presented in Table 4. We measured
the five domains in the EORTC QLQ-C30 questionnaire,
that is, physical function, emotional function, social func-
tion, pain and energy/fatigue. There were no significant
differences in EORTC QLQ-C30 when it was applied in
different diagnoses of cancer (P . 0.05).
Table 1. The sociodemographic data of the patients
n Percent
Age, years (n ¼ 128)
Mean (SD) 47.6 (10.5)
Range 22–70
Sex (n ¼ 128)
Male 9 7.0
Female 119 93.0
Education (n ¼ 128)
No schooling 46 35.9
Elementary school 35 27.3
High school 36 28.1
Undergraduate 7 5.5
Diagnosis of cancer (n ¼ 128)
Cervical cancer 77 60.1
Ovarian cancer 35 27.4
Others 16 12.5
KPS
,90% 73 57.0
90–100% 55 43.0
SD, standard deviation; KPS, Karnofsky Performance Status.
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FACTOR ANALYSIS
Based on the KMO and Bartlett test, the data were suitable
for factor analysis (KMO value was 0.708 and Bartlett test
was 1.765  103, P ¼ 0.000). The extraction of factors was
based on the criterion of an eigenvalue greater than one that
is ten-factor solution with 70.41% of total variance.
Factor analysis results are presented in Table 5. All items
in each domain loaded significantly on one factor of 10
factors. All of the items in physical function, except item 5,
loaded significantly on the first factor. The emotional func-
tion items loaded significantly on the second factor, except
item 23. Pain items loaded significantly on the third factor,
role function and social function items on the fourth factor,
nausea and vomiting items on the fifth factor, general QoL
items on the sixth factor, fatigue items on seventh factor and
cognitive function’ items on the eight factor. Item 23 loaded
significantly on the ninth factor, and item 5 loaded signifi-
cantly on the fifth factor.
EXTERNAL CONVERGENT VALIDITY
The external convergent validity of the questionnaires is pre-
sented in Table 6. This analysis was performed for physical
functioning, social functioning, emotional functioning,
fatigue and pain.
Moderate correlations (0.35–,0.5) were observed in the
physical function and pain domains, whereas the other func-
tions showed low correlations between the questionnaires
(P, 0.05). Otherwise all of the discriminant validity in the
two questionnaires met the r , 0.40 criterion (P, 0.05).
DISCUSSION
This study showed the acceptable psychometric properties of
reliability and validity evaluation of EORTC QLQ-C30 in
our Indonesian version. This scale development will help
clinicians to describe the human side of cancer treatment in
Indonesia. The practicing oncologist can benefit greatly from
the work that was performed in developing and validating
this scale, by applying the instrument to the selection of
treatment modalities based on both treatment efficacy and
the patient’s wishes. In the future, QoL research in Indonesia
will continue to be integrated into the practice of oncology.
The translation of EORTC QLQ-C30 into the Indonesian
language was in compliance with the procedures developed
by the EORTC QoL Study Group (13). The backward trans-
lation of the modified items was compared with the original
versions and was found to be satisfactory. In the pilot study,
the cancer patients were able to complete the questionnaire
in a somewhat longer time than the healthy subjects. This
could be due to the severity of the diseases which made the
patients need more time to focus on completing the question-
naires. The patients’ cognitive function in understanding the
questionnaires could be affected by multiple and severe
symptoms in cancer (16). Nevertheless, all of the patients in
pilot testing were able to fill in the questionnaire by
themselves.
Discrimination in physical function, role function, social
function, global QoL, pain and fatigue in EORTC QLQ-C30
were good (i.e. 0.8% for floor effects and 17.5% for
ceiling effects in social function). However, in the single
items, emotional and cognitive function showed poor
discrimination (i.e. 4.0% for floor effects and 60.3% for
ceiling effects in appetite loss). The poor discriminations
could be related to the means and SDs value of the domains.
All of the functions in SF-36 showed good discrimination,
except for physical role and emotional role. Poor ability
of patients to distinguish the physical and emotional role
or the narrow response of these domains could give rise to
this poor discrimination. All functions with poor
Table 2. Means, SDs, floor–ceiling effects, Cronbach’s a coefficients of
domain in QLQ-C30 and SF-36
Domain Mean SD Floor
(%)
Ceiling
(%)
Cronbach’s a
coefficient
QLQ-C30
Physical function 74.0 21.8 1.6 23.0 0.82
Role function 63.3 24.0 3.2 12.7 0.79
Emotional
function
93.5 12.2 0.8 68.3 0.78
Social function 65.8 23.7 0.8 17.5 0.83
Cognitive
function
93.8 14.3 0.8 79.4 0.82
Global QoL 58.7 16.4 0.8 2.4 0.80
Pain 34.5 26.5 24.6 3.2 0.85
Fatigue 30.2 21.6 15.1 0.8 0.72
Nausea and
vomiting
12.4 21.9 68.3 0.8 0.70
Dyspnea 5.2 18.5 91.3 1.6 Single item
Insomnia 32.4 30.7 39.7 4.0 Single item
Appetite loss 20.0 28.5 60.3 4.0 Single item
Constipation 17.6 27.4 65.1 3.2 Single item
Diarrhea 3.9 15.5 92.1 1.6 Single item
Financial
difficulties
42.2 29.6 22.2 7.1 Single item
SF-36
Physical function 63.9 25.1 1.6 9.5 0.82
Mental health 75.3 18.1 0.8 9.5 0.66
Social function 65.8 23.7 1.6 11.1 0.70
Energy 63.8 18.9 0.8 5.6 0.60
Pain 63.1 29.4 0.8 21.4 0.87
General health 55.3 15.8 0.8 0.8 0.60
Physical role 16.5 33.3 76.2 11.1 0.92
Emotional role 23.2 40.7 73.0 20.6 0.97
QLQ-C30, quality of life core questionnaire; SF-36, Study Short Form 36;
QoL, quality of life.
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discrimination had less than clear descriptions of cancer
patients’ feelings.
Poor discrimination and cancer patients’ feeling could be
affected by anxiety and depression during chemotherapy.
Anxiety and depression may result from excessive feelings of
distress. This psychological distress had significant associ-
ation with memory and concentration (17). Indeed, the small
sample size could effect the poor discrimination. For example
in the nausea symptoms, there were 109 patients who
answered ‘not at all’, and the other patients answered the
other responses. It showed that the patients’ responses were
not distributed normally in all of the responses. Thus, the
floor effect was shown by the nausea symptom. A larger
sample size could result in better distribution responses.
Therefore, the interpretation of this scale in a broad spectrum
of cancer patients must be careful and might need to
be validated when applying it to other types of cancer.
This phenomenon may contribute significantly to poor
discrimination and descriptive assessments. Ideally, the
questionnaires should be given 72 h before the administration
of the chemotherapy (9). However, the system in this hospital
could not trace the patients 2–3 days before administration of
chemotherapy. As a result, the questionnaires were given only
a few hours before chemotherapy. Patients’ memory and con-
centration levels a few hours before chemotherapy could be
affected by patients’ psychological distress.
Table 3. Multi-trait scaling analysis of EORTC QLQ-C30
Item no Description PF RF EF CF SF FA NV PA QL
1 Strenous activity 20.75 20.41 20.04 20.05 0.08 0.22 0.07 20.01 0.03
2 Long walk 20.75 20.32 20.11 20.09 0.08 0.12 20.03 20.02 0.09
3 Short walk 20.69 20.40 20.09 20.11 20.08 0.31 0.05 0.08 0.03
4 Stay in bed/chair 20.61 20.30 20.22 20.05 20.03 0.43 0.17 0.15 20.15
5 Needed help in
eating/dressing/
washing
20.38 20.37 20.45* 20.21 20.17 0.25 0.05 0.34 20.13
6 Limited work 20.34 20.65 20.25 20.12 20.35 0.25 20.06 0.28 0.09
7 Limited hobbies 20.30 20.57 20.18 0.02 20.27 0.31 0.13 0.28 20.04
21 Tense 20.14 20.17 20.65 20.08 20.25 0.14 0.10 0.25 20.05
22 Worried 20.11 20.17 20.64 20.12 20.25 0.16 0.06 0.21 20.08
23 Irritable 20.15 20.15 20.54 20.05 20.12 0.12 0.05 0.14 20.10
24 Depressed 20.03 20.03 20.49 20.11 20.13 20.12 0.01 0.13 20.12
20 Concentration 20.10 20.09 20.25 20.58 20.07 20.11 20.01 20.26 20.14
25 Memory 20.08 20.01 20.01 20.34 20.18 20.04 20.17 0.04 20.04
26 Family life 0.28 20.01 20.12 20.12 20.75 20.03 20.01 0.05 20.11
27 Social life 20.16 20.33 20.09 20.02 20.71 0.17 20.06 0.24 0.02
10 Need rest 20.14 20.17 20.14 20.10 20.21 0.28 20.04 0.05 20.08
12 Feel weak 20.30 20.27 20.29 20.04 20.19 0.40 0.03 0.29 20.10
18 Tired 20.34 20.26 20.32 20.11 20.17 0.50 0.14 0.31 20.10
14 Nausea 20.08 20.09 20.21 20.02 20.24 20.06 0.40 0.15 20.15
15 Vomiting 20.05 20.11 20.21 20.09 20.19 0.13 0.34 0.14 20.15
9 Pain 20.20 20.27 20.26 20.14 20.07 0.16 0.09 0.59 0.07
19 Relation of pain
with daily
activities
20.29 20.38 20.33 20.19 20.15 0.27 0.03 0.60 20.29
29 Overall physical
condition
0.07 0.06 0.23 0.03 0.14 20.07 20.20 20.05 0.62
30 QoL 0.14 0.07 0.25 20.07 0.03 20.19 20.22 20.19 0.65
EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30; PF, physical function; RF, role function;
EF, emotional function; CF, cognitive function; SF, social function; FA, fatigue; NV, nausea and vomiting; PA, pain; QL, quality of life.
The bold numbers showed that the coefficient correlation between the items and its own domain were 0.40.
The number with* showed that the coefficient correlation between the item and other domain was higher than the coefficient correlation of the item and its
own domain. All the values in the boxes were significantly correlated.
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Another possible explanation of these results is that
certain symptoms (dyspnea, insomnia, appetite loss, consti-
pation and diarrhea) were not experienced by the patients, or
that these symptoms were experienced by the patients but
the patients could cope despite these symptoms.
In the SF-36 questionnaires, the internal consistency was
somewhat problematic for mental health, energy and general
health. The low to middle education level of the subjects
could have affected the internal consistency: the subjects
needed more explanation about the response options.
The Cronbach’s a of EORTC QLQ-C30 was acceptable in
all scales.
The convergent and discriminant validity of EORTC
QLQ-C30 were consistent with the results of previous
studies. The EORTC QLQ-C30 in simplified Chinese
version and in Korean cancer patients also met the conver-
gent and discriminant validity (3,18). The low coefficient
correlation in items 5, 15, 20 and 25 may be caused by the
skewed distribution of the responses. Ninety-three percen-
tages of patients gave a ‘not at all’ response for item 5, and
only 4.7% of patients answered ‘very much’ for item 10;
93.8 and 91.4% of patients also answered ‘not at all’ for
items 20 and 25. The previous study in Korean cancer
patients also reported the same problem (18).
In order to examine an additional issue of the psycho-
metric characteristics of the Indonesian version of the
EORTC-QLQ-C30 questionnaire, it was decided to compute
known-groups validity. The known-groups validity analyses
which were performed using different diagnoses of cancer
showed that there were no statistically significant differences
among groups. This fact explained that all of the domains in
EORTC QLQ-C30 were not better in discriminating ovarian,
cervical and other diagnoses of cancer. We acknowledge that
this is just one phase in addressing this issue. Further study
should include additional questionnaires from samples with
varying diagnostic categories of cancer.
The factor analysis showed the satisfactory result that all
items in each domain loaded on one factor. Only role
function and social function loaded on the second factor
together. This factor described the effect of limited role in
social life.
The external convergent validity correlation between
domain of SF-36 and EORTC QLQ-C30 values was under
0.70. Physical Function and Pain had strong correlations in
both questionnaires. However, the moderate and low corre-
lation coefficient in the other domains of SF-36 and EORTC
QLQ-C30 suggest that the subscales were assessing distinct
components of the construct of QoL. The differences can be
explained in the physical function of the SF-36 which con-
tains 10 items, while the EORTC QLQ-C30 only contains
five items. In some items SF-36 has more specific questions
than EORTC QLQ-C30. Nevertheless, the EORTC QLQ-C30
has a broader spectrum of symptoms, such as nausea/vomit-
ing, pain, insomnia, dyspnea, appetite loss, constipation and
diarrhea.
The patients had difficulties in completing the question
numbers 29 and 30 in EORTC QLQ-C30. Therefore, the
instructions of numbers 29 and 30 were modified to facilitate
the patients’ understanding. We also gave some explanations
to the patients related to question numbers 29 and 30.
Another study in China also modified the questions numbers
29 and 30 in EORTC QLQ-C30 to increase the patients’
understanding (2). The translation procedures of previous
studies on EORTC QLQ-C30 in Turkish and Moroccan min-
ority ethnic groups in the Netherlands suggested that the
‘questionnaire was produced for oral administration and
needed some modifications because of the high illiteracy in
Moroccans’ first generation in Netherlands’. The subjects in
this study also need additional information about the
meaning of ‘quality’ word (19). Results of our study were
consistent with the two previous studies, especially in the
short description of questions numbers 29 and 30, also in the
description of the word ‘quality’.
The high internal consistency of EORTC QLQ-C30 is also
consistent with a previous study in patients with chronic
non-malignant pain. Generally, the Cronbach’s a values
observed in this study are higher than those in the patients
with chronic non-malignant pain (4). The low Cronbach’s a
value for cognitive function was also found in the previous
study with various diagnoses of cancer; also homogenous
diagnoses of cancer (20,21). Otherwise, the other studies in
China and Singapore had a lower internal consistency
(,0.70) for physical function and cognitive function in
various diagnoses of cancer (2,15). The finding in our study
was consistent across different cultures.
The known-groups validity of the EORTC QLQ-C30 is
different from a previous study which compared the same
instruments. The emotional function, social function and
pain were significantly different between EORTC QLQ-C30
and SF-36 in the previous study (4). Future research on this
issue is called for.
Factor analysis results of this present study were not con-
sistent with the factor analysis of EORTC QLQ-C30 in
Korean cancer patients, which showed two factors with more
Table 4. Scores of the five QoL domains of QLQ-C30 in the cancer
diagnosis groups
Diagnosis N (%) PF,
Mean
(SD)
EF,
Mean
(SD)
SF,
Mean
(SD)
FA,
Mean
(SD)
PA,
Mean
(SD)
Cervical
cancer
77
(60.1)
72.3
(22.5)
93.9
(11.5)
66.2
(22.5)
31.5
(23.6)
33.9
(26.9)
Ovarian
cancer
35
(27.4)
72.7
(21.6)
92.9
(14.5)
68.0
(24.0)
32.2
(19.6)
35.4
(27.9)
Others 16
(12.5)
81.5
(19.9)
90.0
(14.2)
58.2
(27.9)
23.5
(17.1)
40.4
(25.6)
P value* 0.24 0.72 0.46 0.37 0.80
PF, physical function; EF, emotional function; SF, social function; FA,
fatigue; PA, pain.
*One-way ANOVA test or Kruskal–Wallis test.
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Table 5. Factor analysis of EORTC QLQ-C30
Item Factor
1 2 3 4 5 6 7 8 9 10
PF
Strenous activity 0.833 0.016 20.021 0.225 20.169 0.018 0.092 20.075 20.051 20.008
Long walk 0.832 0.075 0.068 0.062 20.131 20.093 0.085 0.011 0.089 20.100
Short walk 0.790 0.053 0.116 0.199 0.064 0.004 0.028 20.048 20.078 0.025
Stay in bed/chair 0.668 20.095 0.033 0.187 0.193 0.233 0.194 0.064 0.109 0.184
Need help with
eating/dressing/
washing
0.324 0.220 0.097 0.169 0.463 0.017 20.020 0.120 0.049 0.020
RF
Limitation of work
or other daily
activities
0.307 0.166 0.216 0.747 20.004 20.031 0.052 0.044 0.100 0.031
Limitation of
hobbies
0.288 0.186 0.049 0.737 0.134 0.169 20.019 20.051 20.107 0.115
EF
Tense 0.009 0.892 0.159 0.183 0.144 0.027 0.060 20.107 0.080 0.008
Worried 0.003 0.891 0.138 0.141 0.101 0.104 0.076 0.045 0.107 20.044
Irritable 0.228 0.307 0.156 20.103 0.256 0.082 20.019 0.275 0.517 0.344
Depressed 0.080 0.538 0.054 20.140 0.391 0.216 0.173 0.335 0.030 0.070
CF
Concentration 0.034 0.323 0.248 20.101 0.144 0.018 0.076 0.399 20.383 0.095
Memory 20.099 20.022 20.002 0.084 20.140 0.021 0.051 0.805 20.095 0.024
SF
Family life 20.490 0.209 20.055 0.403 0.054 0.038 0.005 0.436 0.267 20.148
Social life 0.095 20.007 20.007 0.719 0.152 20.111 0.314 0.040 0.066 0.005
QL
Overall physical
condition
20.025 20.097 20.119 20.022 20.109 20.855 20.042 20.189 20.067 0.034
Overall QoL 20.012 20.091 20.142 20.002 20.092 20.867 20.177 0.149 0.004 20.095
FA
Need rest 0.185 20.164 0.223 0.370 0.221 0.236 0.160 0.223 0.141 20.040
Felt weak 0.284 0.017 0.252 0.144 0.229 0.108 0.707 0.063 0.107 0.077
18 0.297 0.133 0.178 0.147 0.204 0.156 0.748 0.041 20.046 0.095
NV
Nausea 20.150 0.104 0.027 0.077 0.654 0.180 0.390 20.175 0.043 20.097
Vomiting 20.120 0.141 20.009 0.131 0.793 0.073 0.055 20.060 20.063 0.045
PA
Pain 0.054 0.080 0.753 0.150 0.133 0.103 0.221 20.035 20.024 0.083
Pain interfered
with daily activities
0.133 0.194 0.771 0.226 0.007 20.055 0.210 20.063 200.01 0.158
PF, physical function; RF, role function; EF, emotional function; CG, cognitive function; SF, social function; QL, quality of life; FA, fatigue; NV, nausea
vomiting; PA, pain. The bold numbers showed that the absolute values for loading factor were less than 0.40. All the numbers in the boxes had significant
values.
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than one domain loaded. The ‘emotional distress’ factor
appeared because the EF and CF were loading together in
one factor (18). The variability of cancer diagnoses, patients’
supportive care and patients’ condition during the time they
filled in the questionnaire may cause different results of
factor analysis among the countries.
The result of convergent validity is also consistent with
two previous studies in cancer patients, where the convergent
validity coefficient values ranged from 0.47–0.74 and 0.40
to 0.68 (22,23). Conversely, the study in cancer patients with
chronic pain showed that the coefficients values ranged from
0.70 to 0.80 (4). The correlation coefficients of pain symp-
toms in cancer diagnoses were lower than those in chronic
non-malignant pain patients. This finding illustrates that the
pain level in cancer diagnoses is less important than those of
chronic non-malignant pain. The other symptoms could have
important impacts on QoL, such as nausea and vomiting.
Otherwise, the correlation coefficients between mental and
physical function, energy and mental function in cancer
patients were higher than those in chronic non-malignant
pain patients. Results showed that the correlation of physical
and mental functioning in cancer patients is more important
than the coefficient correlation of physical and mental func-
tion in chronic non-malignant pain. Another study in
Germany indicated that patients had different interpretations
of health subscales of EORTC QLQ-C30, SF-36 and
Functional Living Index-Cancer Questionnaire (FLIC), even
though all three questionnaires had convergent validity in
physical function, emotional function, pain, fatigue and
nausea/vomiting. These results were caused by the different
views of QoL in three questionnaires (23).
The convergent validity in our study was consistent with
another study of questionnaire validation which was done in
Indonesia between Nepean Dyspepsia Index (NDI) and
SF-36. This research also showed low and moderate corre-
lation between the functions in both questionnaires (0.036–
0.638) with P, 0.05 (8).
A limitation of our study is the relatively small and
unequal sample size in each disease group. Even though the
sample size was small and unequal, we believe that this
study is still valid and relevant, because all of the domains
in the EORTC QLQ-C30 were reliable and met the conver-
gent validity, construct validity and test-retest validity. We
also supported the validation analysis with factor analysis
which showed that every domain in the EORTC QLQ-C30
loaded significantly on one factor. A larger sample size of
patients with each type of cancer will facilitate conclusions
on how different types of cancer may affect patients’
responses to the questionnaires.
The result of this scale development process could be
applied to hospitalized patients. Moreover, the scale that we
developed may be limited to those patients treated with cispla-
tin. For the time being, our study results will be used in future
to study QoL only for high-emetogenic cancer treatment. At
the same time, we would like to point out that the sample size
in our study as such is not uncommon in related research.
CONCLUSION
In conclusion, this study provides an Indonesian version of
the EORTC QLQ C-30 questionnaire. Despite the fact that
overall psychometric properties of the instrument were
acceptable, this study indicates the further development of
the instrument in an Indonesian version is required to
achieve ideal tools to measure psychometric properties. The
results of the present study should be confirmed in a study
with increased sample sizes.
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Appendix
Indonesian version of EORTC QLQ-C30.
Kami ingin mengetahui beberapa hal yang berkaitan
dengan Anda dan kesehatan Anda. Jawablah semua perta-
nyaan dengan melingkari angka yang paling sesuai. Tidak
ada jawaban ‘salah’ atau ‘benar’. Informasi yang Anda
berikan akan dirahasiakan.
Tidak Sedikit Sering Sangat Sering
1. Apakah Anda mengalami kesulitan saat melakukan kegiatan yang
berat, seperti membawa barang belanjaan atau koper yang berat?
1 2 3 4
2. Apakah Anda mengalami kesulitan jika berjalan kaki dalam jarak
yang jauh?
1 2 3 4
3. Apakah Anda mengalami kesulitan saat berjalan kaki meskipun
dalam jarak yang pendek, misalnya di sekitar rumah Anda?
1 2 3 4
4. Apakah setiap hari Anda harus berbaring di tempat tidur atau
duduk di kursi ?
1 2 3 4
5. Apakah Anda memerlukan bantuan orang lain saat makan,
berpakaian, mandi atau buang air?
1 2 3 4
Dalam seminggu terakhir:
6. Apakah Anda mengalami keterbatasan saat bekerja atau
melakukan kegiatan sehari-hari lainnya?
1 2 3 4
7. Apakah Anda mengalami keterbatasan saat melakukan kegiatan
santai atau kegiatan yang merupakan hobi Anda?
1 2 3 4
8. Apakah Anda merasa sesak nafas? 1 2 3 4
9. Apakah Anda merasa nyeri? 1 2 3 4
10. Apakah Anda perlu beristirahat? 1 2 3 4
11. Apakah Anda sulit tidur? 1 2 3 4
12. Apakah Anda merasakan badan Anda lemah? 1 2 3 4
Continued
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Continued
Tidak Sedikit Sering Sangat Sering
13. Apakah Anda kehilangan nafsu makan? 1 2 3 4
14. Apakah Anda merasa mual? 1 2 3 4
15. Apakah Anda muntah? 1 2 3 4
16. Apakah Anda sulit buang air besar? 1 2 3 4
Dalam seminggu terakhir
17. Apakah Anda diare? 1 2 3 4
18. Apakah Anda kelelahan? 1 2 3 4
19. Apakah nyeri yang dirasakan mengganggu aktivitas Anda
sehari-hari?
1 2 3 4
20. Apakah Anda sulit berkonsentrasi pada sesuatu hal, seperti
membaca koran atau menonton televisi?
1 2 3 4
21. Apakah Anda merasa tegang? 1 2 3 4
22. Apakah Anda merasa khawatir? 1 2 3 4
23. Apakah Anda merasa mudah tersinggung? 1 2 3 4
24. Apakah Anda merasa depresi? 1 2 3 4
25. Apakah Anda mengalami kesulitan untuk mengingat sesuatu? 1 2 3 4
26. Apakah kehidupan keluarga Anda terganggu oleh kondisi fisik
atau terapi medis yang Anda jalani?
1 2 3 4
27. Apakah aktivitas sosial Anda terganggu oleh kondisi fisik atau
terapi medis yang Anda jalani?
1 2 3 4
28. Apakah Anda mengalami kesulitan keuangan akibat kondisi
fisik atau terapi medis yang dialami?
1 2 3 4
Untuk pertanyaan-pertanyaan berikut ini, lingkari angka yang paling sesuai.
29. Bagaimanakah Anda menilai kondisi kesehatan Anda secara keseluruhan selama seminggu yang lalu?
1 2 3 4 5 6 7
Sangat buruk Sangat baik
30. Bagaimanakah Anda menilai kualitas hidup Anda selama seminggu yang lalu?
1 2 3 4 5 6 7
Sangat buruk Sangat baik
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